| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/30/2009 | CN101543581A Speckle-removing oral liquid |
| 09/30/2009 | CN101543575A Chinese medicinal composition for treating nasosinusitis |
| 09/30/2009 | CN101543565A Chinese medicine external-use preparation medicament for treating surgery wound infection and method for producing the same |
| 09/30/2009 | CN101543563A Vein-relaxing bone-nourishing osteophyte-eliminating ointment and method for preparing same |
| 09/30/2009 | CN101543561A Traditional Chinese medicine preparation for treating breast cancer |
| 09/30/2009 | CN101543555A Combined medicine for treating burn and scald |
| 09/30/2009 | CN101543553A Traditional Chinese medicine composition for regulating qi-flowing and relieving chest stuffiness and pain and quality control method thereof |
| 09/30/2009 | CN101543552A Traditional Chinese medicine preparation for treating lymph node enlargement |
| 09/30/2009 | CN101543551A Traditional Chinese medicine plaster for treating wet rheumatism |
| 09/30/2009 | CN101543546A Antioxidative substance and composition and use thereof |
| 09/30/2009 | CN101543532A Traditional Chinese medicine for treating coronary disease, angina pectoris and apoplexy sequelae and preparation method thereof |
| 09/30/2009 | CN101543527A Drug composition effective for resisting liver damage |
| 09/30/2009 | CN101543525A Beauty composition containing vaccinium vitis-idaea extract and application thereof |
| 09/30/2009 | CN101543516A A detection method for externally applied medicine for hemorrhoids |
| 09/30/2009 | CN101543514A Compound lactobacillus vagina cleaning hygiene body lotion for preventing or treating vaginitis and technology thereof |
| 09/30/2009 | CN101543510A Hyperosteogeny medicine |
| 09/30/2009 | CN101543509A Ophthalmic gel containing chondroitin sulfate and method for preparing same |
| 09/30/2009 | CN101543508A Composition containing water-soluble polyamino sugar derivatives and application thereof |
| 09/30/2009 | CN101543507A Immunostimulatory nucleic acids |
| 09/30/2009 | CN101543506A Compound antibiotic composition for preventing or treating Streptococcus suis |
| 09/30/2009 | CN101543505A Medicine for preventing and treating Alzheimer's disease and preparing method thereof |
| 09/30/2009 | CN101543504A Pharmaceutical composition for resisting osteoporosis |
| 09/30/2009 | CN101543503A Partial compound erythrocin zinc acetate gelling agent and preparation method thereof |
| 09/30/2009 | CN101543502A Novel use of salidroside for prevention and cure for osteoporosis |
| 09/30/2009 | CN101543501A Balsatazide sodium enema liquid and preparation method thereof |
| 09/30/2009 | CN101543500A Dhea composition and method |
| 09/30/2009 | CN101543499A Application of natural compound ursolic acid on antibiosis |
| 09/30/2009 | CN101543498A Application of bitter theophylline in preparing anti-inflammation and analgesic drugs |
| 09/30/2009 | CN101543497A Methods of treating patients suffering from movement disorders |
| 09/30/2009 | CN101543496A Novel pharmaceutical composition of medicament promoting nerve remodeling and preparation method thereof |
| 09/30/2009 | CN101543495A Methods for attaining enhanced sexual wellness using anhydrous compositions |
| 09/30/2009 | CN101543494A Anhydrous compositions useful for attaining enhanced sexual wellness |
| 09/30/2009 | CN101543493A (SBA-15)-nimodipine medicament and preparation method thereof |
| 09/30/2009 | CN101543492A Novel application of dendrobine |
| 09/30/2009 | CN101543491A Application of m-chlorobenzoyl substituted dehydrosilybin for preparing antiviral drugs |
| 09/30/2009 | CN101543490A Application of genistein in medicament preparation for treating hyperplasia of prostate, product and producing method |
| 09/30/2009 | CN101543489A Compounds as liver X receptor modifier |
| 09/30/2009 | CN101543488A A medicine containing caffeic acid 3,4-dihydroxyl phenethyl ester and its uses |
| 09/30/2009 | CN101543487A Antipruritic medical composition for infusing hygenic towelette |
| 09/30/2009 | CN101543486A Application of tetrahydrocurcumin in preparing antidepressant and method for preparing solid dispersion of tetrahydrocurcumin |
| 09/30/2009 | CN101543485A Application of 28 alkanol as anti-Parkinson's disease substance in medicaments and health care products |
| 09/30/2009 | CN101543484A Transdermal drug delivery preparation containing chitin or derivate thereof and preparation method thereof |
| 09/30/2009 | CN101543483A Sinetipin capsule and preparation method and quality detection method thereof |
| 09/30/2009 | CN101543481A Double-layer breviscapine sustained-release tablet and preparation method thereof |
| 09/30/2009 | CN101543479A Terbinafine hydrochloride vaginal effervescent tablet and preparation method thereof |
| 09/30/2009 | CN101543477A Sustained-release microsphere of chitosan-coated 3,5-dihydroxy-4-isopropyl toluylene and preparation method thereof |
| 09/30/2009 | CN101543476A A naringin solid dispersion and the preparation method, and the application thereof |
| 09/30/2009 | CN101543475A Tiamulin fumarate for veterinary use, lung-targeting microsphere of tiamulin fumarate salt and preparation method thereof |
| 09/30/2009 | CN101543474A Lansoprazole sodium submicron emulsion freeze-drying preparation |
| 09/30/2009 | CN101543473A Micro-emulsion composition of etoposide oral medicament, preparation method and application thereof |
| 09/30/2009 | CN101543472A Method for preparing oxaliplatin sustained release suppository |
| 09/30/2009 | CN101543471A Rumen glucose |
| 09/30/2009 | CN101543465A Cosmetic composition comprising imidopercarboxylic acid derivative and n-acylated amino acid ester |
| 09/30/2009 | CN101543298A Rutin chewing agent and method for preparing same |
| 09/30/2009 | CN100545174C Compositions and methods for wt1 specific immunotherapy |
| 09/30/2009 | CN100545161C Heterocyclic derivatives their preparing methods and uses |
| 09/30/2009 | CN100545160C Diamine derivatives |
| 09/30/2009 | CN100545151C Oxazole derivatives of tetracyclines |
| 09/30/2009 | CN100545150C Pyridine ring containing oxazolidinone compounds and preparation process and application thereof |
| 09/30/2009 | CN100544732C Absorbing meneusapogenin compound nebula |
| 09/30/2009 | CN100544731C Pennogenin compound injection preparation |
| 09/30/2009 | CN100544730C Isoglycyrrhiza acid magnesium externally-applied preparation, its making method and usage |
| 09/30/2009 | CN100544729C Isoglycyrrhiza acid magnesium preparation for vein and its making method |
| 09/30/2009 | CN100544728C Anti-scar drug film and its preparing method |
| 09/30/2009 | CN100544727C Medicinal composition for treating Heptitis B |
| 09/30/2009 | CN100544726C DHEA composition and method |
| 09/30/2009 | CN100544725C Androgen pharmaceutical composition and method for treating depression |
| 09/30/2009 | CN100544724C Application of urotropin in preparation of medicament for preventing and treating furfur, scalp itching and hair loss |
| 09/30/2009 | CN100544723C Freeze-dried powder injection containing leucovorin sodium and its preparing method |
| 09/30/2009 | CN100544722C Levodropropizine medicinal composition for oral use |
| 09/30/2009 | CN100544721C Medicine for treating hepatitis B |
| 09/30/2009 | CN100544720C Safe and stable palonosetron injection |
| 09/30/2009 | CN100544719C Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections |
| 09/30/2009 | CN100544718C Use of chemical compound in prepreaing antiviral agents |
| 09/30/2009 | CN100544717C Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
| 09/30/2009 | CN100544716C Process for preparing iris aglycone and use thereof in preparation of medicament for treating atherosclerosis |
| 09/30/2009 | CN100544715C Composition of free-B-ring flavonoids and flavans as a therapeutic agent |
| 09/30/2009 | CN100544714C Composition for solubilization of paclitaxel and preparation method thereof |
| 09/30/2009 | CN100544713C Paclitaxel mixed composition and water-in-oil type emulsion formulation for chemoembolization and preparation method thereof |
| 09/30/2009 | CN100544712C Pharmaceutical composition containing fenofibrate and uses thereof |
| 09/30/2009 | CN100544711C Prostate hyperplasia preventing prescriptions |
| 09/30/2009 | CN100544710C Medical composition of Carmustine, the preparing method and use thereof |
| 09/30/2009 | CN100544709C Oral dispersible pharmaceutical composition of an antithrombotic compound |
| 09/30/2009 | CN100544708C Paeonol soft capsule and its preparing process |
| 09/30/2009 | CN100544705C Texture screening granules containing active components |
| 09/30/2009 | CN100544704C Topical anti-microbial compositions |
| 09/30/2009 | CA2660325A1 Device for local and/or regional delivery employing liquid formulations of therapeutic agents |
| 09/29/2009 | US7595407 Boron complexation strategy for use in manipulating 1-acyldipyrromethanes |
| 09/29/2009 | US7595406 e.g. 2-{4-[1-(cyclohexylmethylamino)ethyl]phenyl}-1H-benzimidazole-4-carboxamide; poly-ADP-ribose polymerase inhibitor; antiinflammatory, anticarcinogenic, antidiabetic, antiischemic agent; neurodegenerative diseases |
| 09/29/2009 | US7595404 Thiazolyl-substituted carbocyclic 1,3-diones as pesticidal agents |
| 09/29/2009 | US7595403 Such as 3-Oxo-3H-benzo[d]isothiazole-2-carboxylic acid allylamide for treating hypercholesterolemia, hyperlipidemia, or atherosclerosis |
| 09/29/2009 | US7595401 6-amino-9H-purines as anticancer agents; 9-[2-(1-Acetylpiperridin-4-yl)ethyl]-8-[(6-bromo-1,3-benzodioxol-5-yl)thio]-9H-purin-6-amine for example |
| 09/29/2009 | US7595400 Synthesis of antitumor agents including camptothecin derivative 9-ethyl-9-hydroxy-1-pentyl-1H,12H-pyrano[3'',4'':6',7']-indolizino[1',2':6,5]pyrido[4,3,2-de]quinazoline-10,13(9H,15H)-dione |
| 09/29/2009 | US7595399 Tyrosine derivatives |
| 09/29/2009 | US7595398 N-(5-membered aromatic ring)-amido anti-viral compounds |
| 09/29/2009 | US7595397 Compounds which modulate the CB2 receptor |
| 09/29/2009 | US7595394 Porphyrin compound, albumin inclusion compound thereof and artificial oxygen carrier |
| 09/29/2009 | US7595347 Pretreatment with alpha, beta-unsaturated aryl sulfone as cytoprotectant; side effect reduction during cancer treatment; mitotic phase cell cycle inhibitor or topoisomerase inhibitors |
| 09/29/2009 | US7595345 side effect reduction; bone disease and psoriasis; compounds display the desirable cell differentiation and antiproliferative effects with reduced calcium mobilization; 2-(4-{1-Ethyl-1-[4-(1-hydroxy-cyclopentylethynyl)-3-methyl-phenyl]-propyl}-2-methyl-benzoylamino)-2-methyl-propionic acid |
| 09/29/2009 | US7595344 Sulphones which modulate the action of gamma secretase |